Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2021 | 2 |
2022 | 2 |
2024 | 2 |
Search Results
6 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Therapy-related Myeloid Neoplasms Following PARP Inhibitors: Real-life Experience.
Clin Cancer Res. 2022 Dec 1;28(23):5211-5220. doi: 10.1158/1078-0432.CCR-22-1622.
Clin Cancer Res. 2022.
PMID: 36201165
[New drug approval: Lisocabtagene maraleucel for patients with relapsed or refractory diffuse large B-cell lymphoma, primary mediastinal B-cell lymphoma or follicular lymphoma grade 3B after two or more lines of systemic treatment].
Chiche E, Loschi M.
Chiche E, et al.
Bull Cancer. 2022 Sep;109(9):879-880. doi: 10.1016/j.bulcan.2022.04.020. Epub 2022 Jun 15.
Bull Cancer. 2022.
PMID: 35717220
French.
No abstract available.
Item in Clipboard
Improving nutritional status after allogeneic stem cell transplantation: results of phase 2 ALLONUT clinical trial.
Estran S, Loschi M, Benachour S, Soldati A, Chiche E, Sammut R, Robert G, Jacquel A, Chibois J, Schneider S, Cluzeau T.
Estran S, et al. Among authors: chiche e.
Bone Marrow Transplant. 2024 Mar 20. doi: 10.1038/s41409-024-02271-w. Online ahead of print.
Bone Marrow Transplant. 2024.
PMID: 38509196
Item in Clipboard
FLT3 Tyrosine Kinase Inhibitors for the Treatment of Fit and Unfit Patients with FLT3-Mutated AML: A Systematic Review.
Loschi M, Sammut R, Chiche E, Cluzeau T.
Loschi M, et al. Among authors: chiche e.
Int J Mol Sci. 2021 May 30;22(11):5873. doi: 10.3390/ijms22115873.
Int J Mol Sci. 2021.
PMID: 34070902
Free PMC article.
Item in Clipboard
Real-life experience with CPX-351 and impact on the outcome of high-risk AML patients: a multicentric French cohort.
Chiche E, Rahmé R, Bertoli S, Dumas PY, Micol JB, Hicheri Y, Pasquier F, Peterlin P, Chevallier P, Thomas X, Loschi M, Genthon A, Legrand O, Mohty M, Raffoux E, Auberger P, Caulier A, Joris M, Bonmati C, Roth-Guepin G, Lejeune C, Pigneux A, Vey N, Recher C, Ades L, Cluzeau T.
Chiche E, et al.
Blood Adv. 2021 Jan 12;5(1):176-184. doi: 10.1182/bloodadvances.2020003159.
Blood Adv. 2021.
PMID: 33570629
Free PMC article.
Item in Clipboard
Comparison of clinical outcomes of several risk stratification tools in newly diagnosed AML patients: A real-world evidence in our current therapeutic era.
Iat A, Loschi M, Benachour S, Calleja A, Chiche E, Sudaka I, Aquaronne D, Ferrero C, Fenwarth L, Marceau A, Fournier E, Dadone-Montaudie B, Cluzeau T.
Iat A, et al. Among authors: chiche e.
Cancer Med. 2024 Mar;13(6):e7103. doi: 10.1002/cam4.7103.
Cancer Med. 2024.
PMID: 38506267
Free PMC article.
Item in Clipboard
Cite
Cite